A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and Performance

NCT ID: NCT07183735

Last Updated: 2025-09-19

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 40 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-07-02
• Study Completion Date: 2024-10-17

Brief Summary

This is a randomized, placebo-controlled crossover study to assess the efficacy of BEAM's Dream Powder in improving sleep health among 40 adults. Participants will use a placebo for 2 weeks, followed by the test product for 4 weeks, with sleep data collected via questionnaires and a Fitbit sleep tracker.

Conditions

Sleep; Sleep Disorder

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: CROSSOVER
• Primary Study Purpose: TREATMENT
• Blinding Strategy: TRIPLE

Study Groups

BEAM Dream Powder

Group Type: EXPERIMENTAL

BEAM Dream Powder

Intervention Type: DIETARY_SUPPLEMENT

A powdered sleep supplement. Administered daily, mixed with 8-12 oz hot water, 30 minutes before bedtime during Weeks 3-6.

Placebo

Group Type: PLACEBO_COMPARATOR

Placebo Control

Intervention Type: DIETARY_SUPPLEMENT

A powdered placebo product. Administered daily, mixed with 8-12 oz hot water, 30 minutes before bedtime during Weeks 1-2.

Interventions

BEAM Dream Powder

A powdered sleep supplement. Administered daily, mixed with 8-12 oz hot water, 30 minutes before bedtime during Weeks 3-6.

Intervention Type: DIETARY_SUPPLEMENT

Placebo Control

A powdered placebo product. Administered daily, mixed with 8-12 oz hot water, 30 minutes before bedtime during Weeks 1-2.

Intervention Type: DIETARY_SUPPLEMENT

Eligibility Criteria

Inclusion Criteria

• Male or female
• 18+ years old
• Self-reported issues with sleeping, falling asleep, or staying asleep.
• Willing to discontinue any supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the study duration.
• Willing to avoid introducing any other supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the duration of this trial.
• Willing to maintain their standard sleep pattern and activity level for the duration of the study.
• Be generally healthy and not live with any uncontrolled chronic disease.

Exclusion Criteria

• Diagnosed with any chronic sleep condition, including but not limited to insomnia, narcolepsy, or sleep apnea.
• Women who are pregnant, breastfeeding, or trying to conceive.
• Anyone unwilling or unable to follow the study protocol.
• Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
• Is currently undergoing, or planning to undergo, any significant medical procedures during the study period.
• Has undergone any surgeries or invasive treatments in the last six months.
• A history of severe allergic reactions, including but not limited to any of the product's ingredients.
• Anyone with a nut allergy.
• Heavy drinkers. A heavy drinker is considered to be a woman who drinks 8 or more alcoholic drinks per week or a man who drinks 15 or more alcoholic drinks per week.
• Anyone who uses illicit drugs.
• Use any prescription medication, over-the-counter, or herbal remedies that can affect sleep.
• Have a job that involves working the third or night shifts.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Citruslabs

INDUSTRY

Sponsor Role: collaborator

Beam

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Citruslabs

Las Vegas, Nevada, United States

Countries

United States

Other Identifiers

20417

Identifier Type: -

Identifier Source: org_study_id